Western Cottonwood Pollen
NDC Package 54575-920-30
Package Information
Western Cottonwood Pollen is immunotherapy using allergenic extracts is indicated for use in patients with severe allergy symptoms (hay fever, rhinitis, etc.) to pollens, molds, insects, animal danders and various other allergens. Marketed by Allergy Laboratories, Inc., this product is identified by NDC 54575-920 and is authorized under FDA application BLA101376.
Identification & Billing
- RxCUI: 1000013 - whole wheat allergenic extract 50 MG/ML Injectable Solution
- RxCUI: 1000013 - whole wheat allergenic extract 0.05 GM/ML Injectable Solution
- RxCUI: 1000013 - whole wheat extract 50 MG/ML Injectable Solution
- RxCUI: 1006300 - Aspergillus niger var. niger allergenic extract 50 MG/ML Injectable Solution
- RxCUI: 1006300 - Aspergillus niger var. niger allergenic extract 0.05 GM/ML Injectable Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 54575 - Allergy Laboratories, Inc.
- 54575-920 - Western Cottonwood Pollen
- 54575-920-30 - 30 mL in 1 VIAL, MULTI-DOSE
- 54575-920 - Western Cottonwood Pollen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (54575-920). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 54575-920-30 identifies a specific commercial package of 30 ml in 1 vial, multi-dose of Western Cottonwood Pollen, labeled by Allergy Laboratories, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Allergy Laboratories, Inc. on December 07, 1967. The current certification is valid through December 31, 2018.
How is this Allergy Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 54575092030. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.